Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public titlesort icon Sponsor State
2010-12-07 Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults BIOCEN Registered
23/03/2020 EGF in bilateral symmetric diabetic neuropathy CIGB Registered outdated
2013-06-20 EGF vaccine- Advanced Lung tumors CIM Registered
2013-06-19 EGF-based vaccine with VChTV Schedule in hormone-refractory prostate tumors CIM Registered
2011-05-03 EGFpeeling I CIGB Registered
20/11/2019 Enhanced recovery protocols in cardiac surgery protocols HHA Registered
2010-12-20 EPANEM-III CIGB Registered
2009-10-23 EPOCIM in benign prostatic hyperplasia. CIMAB Registered
26/01/2017 ESAR-814 Study CIGB Registered
14/04/2020 ESPERANZA study CIGB Registered outdated
13/04/2015 Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. BIOCEN Registered
15/08/2018 Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. BIOCEN Registered outdated
27/04/2022 Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital CNEURO Registered
2010-12-27 Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis CIM Registered
2009-02-12 Evaluation of the antiinflammatory effect of the Vimang® cream in patients with Dermatitis chronic disease. CQF Registered
15/03/2023 Evaluation of the effectiveness of video games for attention intervention in school age boys and girls CNEURO Registered
09/09/2020 Evaluation of the efficacy and safety of the potassium citrate tablet of immediate release vs Acalka® in urolithiasis in adults. LBFO Registered
2009-03-13 Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2 CQF Registered
01/07/2021 Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents CIGB Registered
22/05/2020 Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study FINLAY Registered outdated